CMAX Clinical Research   Report issue

For profit Phase 1 Phase 2
Founded: Adelaide Australia (1993)

Organization Overview

First Clinical Trial
2020
NCT04370431
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CMAX clinical research | CMAX Clinical Research | CMAX Clinical Research Pty Ltd